Balyasny Asset Management
MDXG icon

Balyasny Asset Management’s MiMedx Group MDXG Stock Holding History

Balyasny Asset Management’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,648,100
Closed -$9.06M – 1600
2018
Q3 		$9.06M Buy
1,648,100
+131,900
+9% +$596K 0.04% 522
2018
Q2 		$9.69M Buy
1,516,200
+1,185,200
+358% +$8.44M 0.04% 499
2018
Q1 		$2.31M Sell
331,000
-1,301,900
-80% -$15.2M 0.01% 955
2017
Q4 		$20.6M Buy
1,632,900
+597,900
+58% +$7.29M 0.06% 397
2017
Q3 		$12.3M Buy
1,035,000
+443,700
+75% +$6.58M 0.05% 436
2017
Q2 		$8.85M Buy
+591,300
New +$7.89M 0.04% 572

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Balyasny Asset Management's MDXG Position: Q1 2026 in Review

Balyasny Asset Management sold out of MiMedx Group (MDXG) in Q1 2026, closing a stake of 40,015 shares — an estimated $271K sold.

Balyasny Asset Management first reported a position in MDXG in Q3 2015 and held it in 13 quarters. The position peaked at $22.4M in Q4 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Balyasny Asset Management reported no remaining MiMedx Group position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 40,015 MiMedx Group shares in Q1 2026, an estimated $271K.
  • Balyasny Asset Management first reported a position in MiMedx Group in Q3 2015 and held it in 13 quarters.
  • Balyasny Asset Management's MiMedx Group position peaked at $22.4M in Q4 2017.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.